Pharmaceuticals Projects in India – Page 73

1,542 upcoming and ongoing pharmaceuticals projects in India worth ₹665,172 Cr, with investment, location, project stage and latest status. Last updated 08 Oct 2026.

Projects tracked
1,542
Total investment
₹665,172 Cr
Projects above ₹100 Cr
281
Added in the last 30 days
10

Latest pharmaceuticals projects in India

Showing 361–365 of 1,542
  1. Under Implementation Pharmaceuticals Projects Updated

    New Pharmaceutical Products Mfg. Unit in Dehradun, Uttarakhand

    Uttarakhand Less than 100 Million

    A new pharmaceutical manufacturing unit is planned in the Industrial Area of Selaqui, Dehradun, Uttarakhand, with a production capacity of 1,314.50 tons per annum. The project, with an estimated cost of ₹80 million, is set to begin construction in October 2024 and complete by March 2025. Environmental clearance is currently under review by the State Level Environment Impact Assessment Authority.

    View project
  2. Under Implementation Pharmaceuticals Projects Updated

    Rs.350 Million New API Products Mfg. Project in Palghar, Maharashtra

    Maharashtra From 100 Million to 999 Million

    A new API products manufacturing project is planned in Salwad, Palghar, Maharashtra, focusing on API products, drug intermediates, and fine chemicals, with a capacity of 21,073 tonnes per annum. Estimated at ₹350 million, construction is set to begin in December 2024 and conclude in December 2025. The project is currently undergoing environmental clearance review by the Ministry of Environment.

    View project
  3. Pre Project Stage Pharmaceuticals Projects Updated

    Rs.2500 Million New Medicine Mfg. Project in Chengalpattu, Tamil Nadu

    Tamil Nadu From 1000 Million to 4999 Million

    A significant pharmaceutical manufacturing facility is planned in Chengalpattu, Tamil Nadu, focusing on the production of a diverse range of pharmaceutical tablets, including generics and specialty medications. With an investment of ₹2,500 million, the project aims to enhance manufacturing capacity and meet the growing demand for affordable healthcare solutions. Pre-project activities, including land acquisition and regulatory approvals, are currently in progress.

    View project
  4. Under Implementation Pharmaceuticals Projects Updated

    Rs.650 Million Active Pharmaceutical Ingredients Mfg Expansion Project in Bidar, Karnataka

    Karnataka From 100 Million to 999 Million

    A new synthetic organic chemical project is planned in Bidar district, Karnataka, initially estimated at ₹250 million. As of October 2024, the project focuses on modifying and expanding its Active Pharmaceutical Ingredients (APIs) and custom synthesis manufacturing unit, targeting a capacity of 180.343 tonnes per annum, with a revised cost of ₹650 million. Construction is set to begin in February 2025.

    View project
  5. Under Implementation Pharmaceuticals Projects Updated

    Rs.600 Million Bulk Drugs & Drug Intermediates Mfg. Unit Expansion Project in Telangana

    Telangana From 100 Million to 999 Million

    A pharmaceutical company is planning to expand its bulk drugs and drug intermediates manufacturing unit in Telangana. The expansion will increase production capacity from 25 TPM to 199 TPM within the existing 5.381-acre facility. Estimated at ₹600 million, construction is set to begin in March 2025 and conclude by December 2027. Environmental clearance is pending.

    View project